ストックスクリーナーアプリを入手
22.40
2.00%
0.44
前日終値:
$21.96
開ける：
$22.04
24時間の取引高:
48,297
Relative Volume:
0.63
時価総額：
$251.94M
収益：
$19.85M
当期純損益:
$-12.75M
株価収益率:
-16.23
EPS:
-1.38
ネットキャッシュフロー:
$-21.94M
1週間 パフォーマンス:
+9.97%
1か月 パフォーマンス:
+29.86%
6か月 パフォーマンス:
+23.79%
1年 パフォーマンス:
+37.34%
1日の値動き範囲:
$21.89
$22.50
1週間の範囲:
$20.29
$22.50
52週間の値動き範囲:
$12.78
$24.00
Mediwound Ltd Stock (MDWD) Company Profile
MDWD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
22.39 | 230.42M | 19.85M | -12.75M | -21.94M | -1.38 |
|
ONC
Beone Medicines Ltd Adr
|
245.06 | 25.76B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.65 | 114.53B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.40 | 40.54M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
83.11 | 6.44B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
501.32 | 65.13B | 14.09B | 4.50B | 2.96B | 39.28 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-02 | 開始されました | Alliance Global Partners | Buy |
| 2025-02-28 | 開始されました | Craig Hallum | Buy |
| 2024-07-16 | 繰り返されました | Maxim Group | Buy |
| 2022-12-22 | 開始されました | Maxim Group | Buy |
| 2022-07-18 | 再開されました | Oppenheimer | Outperform |
| 2020-09-23 | 開始されました | BTIG Research | Buy |
| 2016-11-28 | 開始されました | Aegis Capital | Buy |
| 2016-08-17 | 開始されました | Wells Fargo | Outperform |
| 2014-04-16 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Mediwound Ltd (MDWD) 最新ニュース
Oppenheimer assumes MediWound stock at outperform, sets $34 PT By Investing.com - Investing.com India
Oppenheimer Adjusts MediWound Price Target to $34 From $36, Maintains Outperform Rating - marketscreener.com
MediWound (MDWD) Garners Outperform Rating with Strategic Advanc - GuruFocus
Companies Like MediWound (NASDAQ:MDWD) Are In A Position To Invest In Growth - Yahoo Finance
What is HC Wainwright’s Forecast for MediWound Q2 Earnings? - Defense World
Northern Trust Corp Has $2.58 Million Holdings in MediWound Ltd. (NASDAQ:MDWD) - Defense World
MediWound (NASDAQ:MDWD) PT Set at $31.00 by HC Wainwright - Defense World
Where are the Opportunities in (MDWD) - news.stocktradersdaily.com
H.C. Wainwright lifts MediWound stock target to $31, maintains buy By Investing.com - Investing.com South Africa
H.C. Wainwright lifts MediWound stock target to $31, maintains buy - Investing.com
MDWD: HC Wainwright & Co. Raises Price Target for MediWound | MD - GuruFocus
MediWound (MDWD) Target Price Raised by Analyst | MDWD Stock News - GuruFocus
MediWound (MDWD) Target Price Raised by Analyst | MDWD Stock New - GuruFocus
MediWound Ltd (MDWD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Decline - Yahoo Finance
MediWound’s Q1 2025: Strategic Progress Amid Financial Challenges - TipRanks
Mediwound earnings beat by $0.58, revenue fell short of estimates - Investing.com India
MediWound (MDWD) Q1 2025 Earnings Call Transcript - Mitrade
MediWound: Q1 Earnings Snapshot - MySA
MediWound Q1 2025 Earnings Call Transcript - MarketBeat
Transcript : MediWound Ltd., Q1 2025 Earnings Call, May 21, 2025 - marketscreener.com
MediWound Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
MediWound Ltd. Reaffirms Revenue Guidance for the Year 2025 - marketscreener.com
MediWound (MDWD) Projects Revenue Growth for Fiscal Year 2025 | - GuruFocus
MediWound Announces Q1 2025 Results and Updates on Key Trials - TipRanks
MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times
MediWound (MDWD): Q1 Revenue Falls Short, Strategic Growth Plans Intact | MDWD Stock News - GuruFocus
MediWound Expands Global Reach: Major Wound Care Players Join Clinical Trials as Revenue Targets $24M - Stock Titan
Earnings To Watch: MediWound Ltd (MDWD) Reports Q1 2025 Result - GuruFocus
MediWound Stock: Undervalued High-Growth Potential (NASDAQ:MDWD) - Seeking Alpha
MediWound Announces Key Approvals at 2025 Shareholder Meeting - TipRanks
We Think MediWound (NASDAQ:MDWD) Can Afford To Drive Business Growth - simplywall.st
MediWound (MDWD) to Release Earnings on Wednesday - Defense World
MediWound (MDWD) Showcases Phase II Trial Results in Wound Care - GuruFocus
EscharEx shows promise in venous ulcer treatment - Investing.com Australia
MediWound Announces Publication of Phase II EscharEx® Data Demon - GuruFocus
MediWound Announces Publication of Phase II EscharEx® Data - GlobeNewswire
MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers - Stock Titan
Barclays PLC Raises Stock Position in MediWound Ltd. (NASDAQ:MDWD) - Defense World
MediWound Ltd. (NASDAQ:MDWD) Shares Sold by Renaissance Technologies LLC - Defense World
Will VALUE Add More Value To MediWound? - RTTNews
MediWound to Report First Quarter 2025 Financial Results - The Manila Times
Enzymatic Therapeutics Leader MediWound Sets Q1 2025 Earnings CallKey Updates Expected - Stock Titan
MediWound (NASDAQ:MDWD) Earns Buy Rating from Analysts at Alliance Global Partners - Defense World
(MDWD) Technical Data - news.stocktradersdaily.com
MediWound (MDWD) Gains Buy Rating with Promising Future Prospect - GuruFocus
MediWound (MDWD) Gains Buy Rating with Promising Future Prospects | MDWD Stock News - GuruFocus
Mediwound Ltd (MDWD) 財務データ
収益
当期純利益
現金流量
EPS
1.76%
0.89%
大文字化:
|
ボリューム (24 時間):